Compare · BUD vs SRXH
BUD vs SRXH
Side-by-side comparison of Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD) and SRX Health Solutions Inc. (SRXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BUD and SRXH operate in Beverages (Production/Distribution) (Consumer Staples), so they compete in similar markets.
- BUD is the larger of the two at $160.29B, about 6327.8x SRXH ($25.3M).
- Over the past year, BUD is up 33.0% and SRXH is down 94.1% - BUD leads by 127.1 points.
- SRXH has hit the wire 5 times in the past 4 weeks while BUD has been quiet.
- BUD has more recent analyst coverage (25 ratings vs 0 for SRXH).
- Company
- Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
- SRX Health Solutions Inc.
- Price
- -
- -
- Market cap
- $160.29B
- $25.3M
- 1M return
- +4.76%
- -27.33%
- 1Y return
- +33.05%
- -94.06%
- Industry
- Beverages (Production/Distribution)
- Beverages (Production/Distribution)
- Exchange
- NYSE
- AMEX
- IPO
- 2021
- News (4w)
- 0
- 5
- Recent ratings
- 25
- 0
Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev SA/NV engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium. Anheuser-Busch InBev SA/NV is a subsidiary of AB InBev NV/SA.
Latest BUD
- Anheuser-Busch Invests $23 Million in Fort Collins, CO Brewery to Drive Local Economic Growth, Expands Local Manufacturing Skills Training
- Anheuser-Busch Invests $21 Million in Los Angeles, CA Facilities, Expands Local Manufacturing Skills Training
- Anheuser-Busch InBev upgraded by Deutsche Bank
- Netflix and Stella Artois Bring the Perfect Serve to The Gentlemen Season 2
- Anheuser-Busch Invests $13 Million in Baldwinsville, NY Brewery, Expands Local Manufacturing Skills Training
- Tunnel to Towers Foundation & Anheuser-Busch Expand Longstanding Partnership in Honor of the 25th Anniversary of 9/11
- NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
- ‘Cheers to Beer’ Celebrates the Drink at the Heart of Life’s Meaningful Moments
- SEC Form 6-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
- SEC Form 6-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Latest SRXH
- SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
- SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
- SEC Form 8-K filed by SRX Health Solutions Inc.
- SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
- SEC Form 8-K filed by SRX Health Solutions Inc.
- SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
- SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
- SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
- SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits